Peterson Named an NHLBI Division Director
Dr. Charles Peterson has been named director of the Division of
Blood Diseases and Resources (DBDR), NHLBI. Since joining
NHLBI in 1998, he has served as director of DBDR's Blood
Diseases Program. In that capacity he has overseen the
development of a thalassemia clinical research network as well as
a clinical research network in blood and marrow transplantation.
Peterson received his medical degree in 1969 from Columbia
College of Physicians and Surgeons in New York. He has been
awarded 5 patents dealing with methods for glucose, lipid and
alcohol measurement. A member of the American Society of
Hematology, he has published 157 peer-reviewed papers, which
have included extensive work in hemoglobinopathies. In addition,
he has published more than 190 reviews, chapters and editorials
and has edited more than 20 monographs. He succeeds Dr.
Barbara Alving, who was appointed deputy director, NHLBI.
Two Welcomed as NIGMS Councillors
Acting NIGMS director Dr. Judith Greenberg (r) recently
welcomed two new members to the National Advisory General
Medical Sciences Council: Dr. Ira Herskowitz (c) is codirector of
the program in human genetics in the School of Medicine at the
University of California, San Francisco, where he is also a
professor in the department of biochemistry and biophysics. His
research interests include the control of gene expression in yeast,
cell signaling, cell morphogenesis and growth control, and
pharmacogenetics. Dr. Laura Weiss Roberts is an associate
professor and vice chair for administration in the department of
psychiatry at the University of New Mexico School of Medicine.
She recently founded and is the director of the University of New
Mexico Health Sciences Center Institute for Ethics. Since 1996,
she has served as director of the empirical ethics group, a
multidisciplinary research team focusing on ethical issues in
clinical care and research with special populations.
Five Members Join NIAMS Council
The National Institute of Arthritis and Musculoskeletal and Skin Diseases advisory council recently added five new members.
Vicki Kalabokes is president and chief executive officer of the National Alopecia Areata Foundation in San Rafael, Calif. She coordinates medical research at over 40 university centers worldwide and serves as a member of the NIH Council of Public Representatives.
 |
| NIAMS director Dr. Steven Katz (third from l) and deputy director Dr. Steven Hausman (r) welcome new council members (from l) Dr. Richard T. Moxley, Dr. Francesco Ramirez, Dr. Cato T. Laurencin, Vicki Kalabokes and Mary Elizabeth Replogle. |
Dr. Cato T. Laurencin is the Helen I. Moorehead distinguished professor of chemical engineering at Drexel University and clinical professor of orthopaedic surgery at the Medical College of Pennsylvania Hahnemann School of Medicine. He also serves as director of the Center for Advanced Biomaterials and Tissue Engineering at Drexel, where his research involves overseas development of new polymer systems for biomedical purposes as well as tissue engineering and drug delivery.
Dr. Richard T. Moxley III is director of the Neuromuscular Disease Center, associate chair of the department of neurology, and a professor of pediatrics and neurology at the University of Rochester School of Medicine. He is currently studying muscle wasting and weakness in the muscular dystrophies, and has a special interest in the myotonic dystrophies and Duchenne dystrophy.
Dr. Francesco Ramirez is currently the Dr. Amy and James Elster professor of molecular biology at the department of pharmacology and biological chemistry, as well as the dean for research and vice president of Mt. Sinai School of Medicine at New York University. He will soon be leaving to take a new job as chief scientific officer for special surgery at Weill Medical College of Cornell University.
Mary Elizabeth Replogle is vice chairman of the Oklahoma Arthritis Network, a statewide coalition of nearly 200 organizations, businesses and individuals working to bring about the state's Arthritis Action Plan.
Up to Top